XERS   $3.08  1.32% Market Closed After Close 3.1 0.65%

Xeris Biopharma Holdings Inc
Total Cash 77.57M
totalCashPerShare 0.521
EBITDA -25.00M
Total Debt 269.80M
quickRatio 1.59
currentRatio 2.257
Total Revenue 181.41M
debtToEquity
Revenue/Share 1.284
ROA -0.07037
ROE
grossProfits
freeCashflow -38.89M
operatingCashflow -37.79M
earningsGrowth
revenueGrowth 0.265
grossMargins 0.83721
ebitdaMargins -0.1378
operatingMargins -0.17033
profitMargins -0.32833
enterpriseValue 677.97M
forwardPE -13.36
floatShares 142.42M
sharesOutstanding 149.00M
sharesShort 11.57M
sharesShortPriorMonth 11.00M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.41%
Short Ratio help_outline 8.56%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue -0.129
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -59.56M
trailingEps -0.42%
forwardEps -0.25%
enterpriseToEbitda -27.12
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.09 3Q 2024
institutionsCount 178
lastUpdated Nov. 7, 2024, 2:50 a.m.